Galapagos Genomics Ord

(GLPGF)

By |

Profile

Galapagos NV is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.

Contact Information

Website: www.glpg.com
Email: ir@glpg.com
Main Phone: +32 15342900
Address: Generaal De Wittelaan L11 A3
City / Town: Mechelen
Country: BEL
Postal Code: 2800

Issuer Information

Exchange: GREY
CEO: Onno van de Stolpe
Employees: 779


Gathering Data... Please wait

Profile

Galapagos NV is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.

Contact Information

Website: www.glpg.com
Email: ir@glpg.com
Main Phone: +32 15342900
Address: Generaal De Wittelaan L11 A3
City / Town: Mechelen
Country: BEL
Postal Code: 2800

Issuer Information

Exchange: GREY
CEO: Onno van de Stolpe
Employees: 779
$ 172.05 $ 0. (0.00%)
Last Price 172.05 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 172.05
Last Trade Volume 6 52 Wk Hi 172.05 52 Wk Low 95.91
Market Cap 9.4 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 54,823,101.00 EPS (TTM) -0.81 PE Ratio N/A Exchange Greys